Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Japanese Journal of Ophthalmology|May 7, 2025
Evaluation of changes in retinal light sensitivity thresholds in the early postoperative days after trabeculectomy using microperimetryTakeshi Yoshida, Sho Ogawa, Takayuki Miki, et al.The Journal of Pharmacology and Experimental Therapeutics|December 16, 2018
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic RatsHiroto Oshima, Takayuki Miki, Atsushi Kuno, et al.Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|December 6, 2024
Visualization of the scleral structure changes at various stages of eyes with myopic maculopathy using polarization-sensitive OCTKeigo Sugisawa, Hiroyuki Takahashi, Masahiro Yamanari, et al.Journal of Molecular and Cellular Cardiology|January 8, 2016
Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathyToshiyuki Yano, Shinya Shimoshige, Takayuki Miki, et al.Plos One|December 21, 2017
Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitusKei Nakata, Takayuki Miki, Masaya Tanno, et al.The Journal of Pharmacology and Experimental Therapeutics|December 27, 2005
Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodelingTakayuki Miki, Tetsuji Miura, Toshiyuki Yano, et al.Journal of Molecular and Cellular Cardiology|May 8, 2018
Translational regulation by miR-301b upregulates AMP deaminase in diabetic heartsYuki Tatekoshi, Masaya Tanno, Hidemichi Kouzu, et al.Clinical and Experimental Nephrology|March 17, 2021
Involvement of necroptosis in contrast-induced nephropathy in a rat CKD modelSatoru Shibata, Norihito Moniwa, Atsushi Kuno, et al.Journal of Molecular and Cellular Cardiology|January 21, 2015
Excessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heartHidemichi Kouzu, Takayuki Miki, Masaya Tanno, et al.Journal of Diabetes Investigation|January 22, 2019
Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic ratsYukishige Kimura, Atsushi Kuno, Masaya Tanno, et al.Pageof 10